IP Library Patent Application 11344045
Patent Application
App. No. 11/344,045

Semiconductor nanocrystal complexes and methods of detecting molecular interactions using same

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/344,045
Abstract

A water-stable semiconductor nanocrystal complex adapted to act as a FRET donor. The present invention also provides a method of detecting molecular interactions in an aqueous solution between a FRET acceptor and a semiconductor nanocrystal complex that is a FRET donor.

Claims (38)

1 . A semiconductor nanocrystal complex comprising:

a semiconductor nanocrystal;

a surfactant layer surrounding the semiconductor nanocrystal, the surfactant having a moiety with an affinity for the semiconductor nanocrystal and a moiety with an affinity for a hydrophobic solvent; and

an additional layer having a hydrophobic end for interacting with the surfactant layer and a hydrophilic end, wherein the semiconductor nanocrystal complex is adapted to act as a fluorescence resonance energy transfer (FRET) donor.

2 . The semiconductor nanocrystal complex of claim 1 , wherein the semiconductor nanocrystal comprises a semiconductor nanocrystal shell overcoating a semiconductor nanocrystal core.

3 . The semiconductor nanocrystal complex of claim 1 , wherein the hydrophilic end of the additional layer comprises a functional group for coupling to one or more tertiary molecules.

4 . The semiconductor nanocrystal complex of claim 3 , further comprising a tertiary molecule coupled to the functional group.

5 . The semiconductor nanocrystal complex of claim 4 , wherein the tertiary molecule is a member of a specific binding pair.

6 . The semiconductor nanocrystal complex of claim 5 , wherein the member of the specific binding pair is selected from the group consisting of antibody, antigen, hapten, antihapten, biotin, avidin, streptavidin, IgG, protein A, protein G, drug receptor, drug, toxin receptor, toxin, carbohydrate, lectin, peptide receptor, peptide, protein receptor, protein, carbohydrate receptor, carbohydrate, polynucleotide binding protein, polynucleotide, DNA, RNA, aDNA, aRNA, enzyme, substrate.

7 . The semiconductor nanocrystal complex of claim 4 , wherein the tertiary molecule is selected from the group consisting of an polypeptide, glycopeptide, peptide nucleic acid, oligonucleotide, aptamer, cellular receptor molecule, enzyme cofactor, oligosaccharide, a liposaccharide, a glycolipid, a polymer, a metallic surface, a metallic particle, and a organic dye molecule.

8 . The semiconductor nanocrystal complex of claim 1 , wherein the distance between the semiconductor nanocrystal and the additional layer is less than 100 Angstroms.

9 . The semiconductor nanocrystal complex of claim 8 , wherein the distance between the semiconductor nanocrystal and the additional layer is less than 90 Angstroms.

10 . The semiconductor nanocrystal complex of claim 9 , wherein the distance between the semiconductor nanocrystal and the additional layer is less than 80 Angstroms.

11 . The semiconductor nanocrystal complex of claim 10 , wherein the distance between the semiconductor nanocrystal and the additional layer is less than 70 Angstroms.

12 . The semiconductor nanocrystal complex of claim 3 , wherein the distance between the semiconductor nanocrystal and the functional group is less than 100 Angstroms.

13 . The semiconductor nanocrystal complex of claim 12 , wherein the distance between the semiconductor nanocrystal and the functional group is less than 90 Angstroms.

14 . The semiconductor nanocrystal complex of claim 13 , wherein the distance between the semiconductor nanocrystal and the functional group is less than 80 Angstroms.

15 . The semiconductor nanocrystal complex of claim 14 , wherein the distance between the semiconductor nanocrystal and the functional group is less than 70 Angstroms.

16 . The semiconductor nanocrystal complex of claim 4 , wherein the distance between the semiconductor nanocrystal and the tertiary molecule is less than 100 Angstroms.

17 . The semiconductor nanocrystal complex of claim 16 , wherein the distance between the semiconductor nanocrystal and the tertiary molecule is less than 90 Angstroms.

18 . The semiconductor nanocrystal complex of claim 17 , wherein the distance between the semiconductor nanocrystal and the tertiary molecule is less than 80 Angstroms.

19 . The semiconductor nanocrystal complex of claim 18 , wherein the distance between the semiconductor nanocrystal and the tertiary molecule is less than 70 Angstroms.

20 . The semiconductor nanocrystal complex of claim 1 , wherein the semiconductor nanocrystal complex has a quantum yield of over 10% as measured under ambient conditions.

21 . The semiconductor nanocrystal complex of claim 1 , wherein the semiconductor nanocrystal complex has a quantum yield of over 20% as measured under ambient conditions.

22 . The semiconductor nanocrystal complex of claim 1 , wherein the semiconductor nanocrystal complex has a quantum yield of over 35% as measured under ambient conditions.

23 . The semiconductor nanocrystal complex of claim 1 , wherein the semiconductor nanocrystal complex has a quantum yield of over 50% as measured under ambient conditions.

24 . The semiconductor nanocrystal complex of claim 1 , wherein the semiconductor nanocrystal complex has an energy transfer greater than 30%.

25 . The semiconductor nanocrystal complex of claim 1 , wherein the semiconductor nanocrystal complex has an energy transfer greater than 40%.

26 . The semiconductor nanocrystal complex of claim 1 , wherein the semiconductor nanocrystal complex has an energy transfer greater than 50%.

27 . A method of detecting an acceptor molecule in a aqueous solution comprising:

introducing the semiconductor nanocrystal complex of claim 4 into an aqueous solution;

exciting the semiconductor nanocrystal complex;

determining a light emission from the aqueous solution containing the semiconductor nanocrystal complex; and

detecting the presence of an acceptor molecule in the aqueous solution based on the light emission.

28 . The method of claim 27 , wherein the distance between the semiconductor nanocrystal complex and the acceptor molecule is between 1 and 10 nanometers.

29 . The method of claim 27 , wherein the distance between the semiconductor nanocrystal complex and the tertiary molecule is less than 100 Angstroms.

30 . The method of claim 27 , wherein the semiconductor nanocrystal complex has a quantum yield of over 10%.

31 . The method of claim 27 , wherein the semiconductor nanocrystal complex has an energy transfer greater than 30%.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Dec 17, 2010
From: LC CAPITAL MASTER FUND, LTD; OPALKA FAMILY INVESTMENT PARTNERS, LP; ROBB, WALTER L.; SINGER CHILDREN'S MANAGEMENT TRUST; CHALIS CAPITAL LLC; BAZCO, LLC; BIRCH HOLDINGS, LLC; SOLA LTD
To: EVIDENT TECHNOLOGIES, INC.
Reel/Frame 025521/0260 →
RELEASE OF SECURITY INTEREST Recorded Nov 5, 2010
From: JOHN JOSEPH GORMAN V TRUST; TEJAS SECURITIES GROUP, INC. 401K PLAN AND TRUST FBO JOHN J. GORMAN, JOHN GORMAN TRUSTEE; RYLEIGH GORMAN TRUST; GREYWOLF CAPITAL PARTNERS II, LP; LC CAPITAL MASTER FUND, LTD; MILLENIUM FIXED INCOME, LP; OPALKA FAMILY INVESTMENT PARTNERS, LP; WALTER L. ROBB; SINGER CHILDREN'S MANAGEMENT TRUST; BENJAMIN E. NICKOLL; FREDERICK WAHL; JOHN J. COLTON; MICHAEL WOLF; MORRIS WEISS; ZACHARY PASSERETTI, MD; CHALIS CAPITAL LLC; BAZCO, LLC; BIRCH HOLDINGS, LLC; SOLA LTD
To: EVIDENT TECHNOLOGIES, INC.
Reel/Frame 025320/0871 →
RELEASE OF SECURITY INTEREST Recorded Nov 5, 2010
From: JOHN JOSEPH GORMAN V TRUST; TEJAS SECURITIES GROUP, INC.; RYLEIGH GORMAN TRUST; GREYWOLF CAPITAL PARTNERS II, LP; LC CAPITAL MASTER FUND, LTD; MILLENIUM FIXED INCOME, LP; OPALKA FAMILY INVESTMENT PARTNERS, LP; ROBB, WALTER L.; SINGER CHILDREN'S MANAGEMENT TRUST; NICKOLL, BENJAMIN E.; WAHL, FREDERICK; COLTON, JOHN J.; WOLF, MICHAEL; WEISS, MORRIS; PASSERETTI, ZACHARY MD; CHALIS CAPITAL LLC; BAZCO, LLC; SOLA LTD
To: EVIDENT TECHNOLOGIES, INC.
Reel/Frame 025321/0665 →
SECURITY AGREEMENT Recorded May 26, 2010
From: EVIDENT TECHNOLOGIES
To: LC CAPITAL MASTER FUND, LTD; OPALKA FAMILY INVESTMENT PARTNERS, LP; WALTER L. ROBB C/O VANTAGE MANAGEMENT, INC.; SINGER CHILDREN'S MANAGEMENT TRUST C/O ROMULUS HOLDINGS INC.; CHALIS CAPITAL LLC; BAZCO, LLC; BIRCH HOLDINGS, LLC; SOLA LTD C/O SOLUS ALTERNATIVE ASSET MANAGEMENT LP
Reel/Frame 024434/0534 →
PATENT COLLATERAL SECURITY AGREEMENT Recorded Jan 9, 2008
From: EVIDENT TECHNOLOGIES, INC.
To: JOHN JOSEPH GORMAN V TRUST; TEJAS SECURITIES GROUP, INC. 401K PLAN AND TRUST FBO JOHN J. GORMAN, JOHN GORMAN TRUSTEE; RYLEIGH GORMAN TRUST; GREYWOLF CAPITAL PARTNERS II, LP; LC CAPITAL MASTER FUND, LTD; MILLENIUM FIXED INCOME, LP; OPALKA FAMILY INVESTMENT PARTNERS, LP; ROBB, WALTER L.; SINGER CHILDREN'S MANAGEMENT TRUST; NICKOLL, BENJAMIN E.; WAHL, FREDERICK; COLTON, JOHN J.; WOLF, MICHAEL; WEISS, MORRIS; PASSARETTI, ZACHARY, MD; CHALIS CAPITAL LLC; BAZCO, LLC; BIRCH HOLDINGS, LLC; SOLA LTD
Reel/Frame 020339/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2006
From: LUI, WEI; BROGAN, LOUISE
To: EVIDENT TECHNOLOGIES
Reel/Frame 018214/0731 →